STE Stock Analysis: Buy, Sell, or Hold?
STE - STERIS plc
$215.98
4.88 (2.31%)
▲
5d:
+1.07%
30d:
-2.49%
90d:
-11.56%
BUY
HIGH Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 11, 2026
0d
Smart Money Accumulation
STE is down 4.9% this week, but smart money is accumulating calls. Top strike: $250 2026-06-18 with 134 OI. Call ratio: 83% View Scanner →
Strength: 5.8/10
Get Alerted When STE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called STE this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: STE appears deeply undervalued. Market expects -4.2% annual earnings decline despite 52% recent earnings growth. Contrarian opportunity at discount to historical valuation.
✅ BUY SIGNAL: STE appears deeply undervalued. Market expects -4.2% annual earnings decline despite 52% recent earnings growth. Contrarian opportunity at discount to historical valuation.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$332.12
Based on 6.3% avg growth
INTRINSIC VALUE TODAY
$206.22
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: STE is currently trading at $215.98, which is considered oversold relative to its 30-day fair value range of $212.51 to $224.65. From a valuation perspective, the stock is trading at a discount (Forward PE: 19.5) compared to its historical average (22.1). Remarkably, the market is currently pricing in an annual earnings decline of 4.2% over the next few years. This pessimistic expectation contrasts with the company's recent 52.2% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, STE is in a strong downtrend. The price is approaching resistance at $218.34. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $256.86 (+18.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, STE is in a strong downtrend. The price is approaching resistance at $218.34. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $256.86 (+18.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$212.51 -
$224.65
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
77.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($256.86)
Trading Range Analysis
30-Day Trading Range
$212.51 -
$224.65
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$195.14
Resistance Level
$218.34
Current Trend
Strong Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.49
Wall Street Target
$256.86
(+18.9%)
Revenue Growth (YoY)
7.3%
Earnings Growth (YoY)
52.2%
Profit Margin
13.2%
Valuation Discount vs History
-4.2% cheaper
PE vs Historical
19.5 vs 22.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.2%
(market-implied from PE analysis)
1-Year Target
$206.91
(-4%)
2-Year Target
$198.22
(-8%)
3-Year Target
$189.89
(-12%)
3-Yr Target (if PE normalizes)
(PE: 19→22)
$215.27
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.0, Growth: 8.6%)
$312.88
(+45%)
Base:
(SPY PE: 19.5, Growth: 8.6%)
$276.75
(+28%)
Bear:
(PE: 16.6, Growth: 8.6%)
$235.24
(+9%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (27x PE), but valuation improves significantly next year (19x PE) as earnings recover.
Trailing PE: 26.59 | Current EPS (TTM): $7.94
Bull Case
$324.01
(+50%)
Analyst growth 39.5%, PE expands to 29.3
Base Case
$294.55
(+36%)
Market implied 39.5%, PE stable at 26.6
Bear Case
$143.55
(-34%)
Severe decline -20.0%, PE contracts to 22.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 19.5 to 22.1
Stabilization Target:
$244.84
(+13.4%)
PE Expansion Potential:
+13.4%
Share & Embed Analysis
Last updated: May 15, 2026 9:11 AM ET
Data refreshes hourly during market hours. Next update: 10:11 AM
Data refreshes hourly during market hours. Next update: 10:11 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is STE showing a specific setup today?
Insider Activity (6 Months)
4
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-03-30
Ro Khanna
SELL
2026-03-23
April McClain Delaney
BUY
2026-03-16
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 55 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$392 | 62 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 62 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 53 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$250 | 58 HOLD |
Advanced STE Option Strategies
Professional options setups generated by AI based on today's STE price and gamma walls.
